Free shipping on all orders over $ 500

| Popular Products

| New ProductsView More »

Cat.No.  Name Information
M66454 3-Hydroxyhippuric acid 3-Hydroxyhippuric acid inhibits homo sapiens kynureninase (Ki=60 μM). 3-Hydroxyhippuric acid is an acylglycine, it is one of the major metabolites of catechin-rich and wine polyphenol-rich diets. 3-Hydroxyhippuric acid is a biomarker for Clostridium and is positively correlated with the content of Clostridium.
M66453 DSPE-PEG2000-SH DSPE-PEG2000-SH is an amphiphilic thiol-functionalized DSPE-PEG molecule. DSPE-PEG2000-SH inserts into extracellular vesicle (EV) bilayer membranes via hydrophobic interactions, displaying surface thiol groups to form EV-SH crosslinkers. DSPE-PEG2000-SH can be used to encapsulate agents for drug delivery system, such as mRNA vaccine.
M66452 Caracemide Caracemide (NSC-253272) inhibits the enzyme ribonucleotide reductase of Escherichia coli.
M66450 Tiludronate disodium Tiludronate (Tiludronic Acid) disodium, an orally active bisphosphonate, can act an osteoregulator. Tiludronate is used for the research of the metabolic bone disorders.
M66449 L-NIL dihydrochloride L-NIL dihydrochloride is an inducible NO synthase inhibitor, with an IC 50 of 3.3 μM for miNOS.
M66448 NFATc1-IN-1 NFATc1-IN-1 is a potent inhibitor of RANKL-induced osteoclast formation, with an IC 50 of 1.57 μM.
M66447 Petrelintide Petrelintide (ZP8396) is a dual amylin and calcitonin receptor agonist (DACRA) Petrelintide elicits a selective reduction in high-fat diet intake in diet-induced obese (DIO) rats.
M66446 VAF347 VAF347 is a cell permeable and highly affinity aryl hydrocarbon receptor (AhR) agonist and induces AhR signaling.
M66445 Darlifarnib Darlifarnib (KO-2806) is an orally active farnesyl transferase inhibitor. Darlifarnib inhibits the mTORC1 signaling pathway.

| Publications & Patents
  Citing AbMole Products

  •   US20260116871A1. 2026 Apr
  •   US20260078129A1. 2026 Mar
  •   US20250304578A1. 2025 Oct
  •   US20250034496A1. 2025 Jan
  •   WO2026062223A1. 2026 Mar
  •   WO2026055238A1. 2026 Mar
  •   WO2025259108A1. 2025 Dec
  •   WO2025229179A1. 2025 Nov
  •   WO2025223036A1. 2025 Oct
  •   WO2025176679A1. 2025 Aug
  •   KR20260056832A. 2026 Apr
  •   KR20260049434A. 2026 Apr
  •   KR20260038830A. 2026 Mar
  •   EP4700123A2. 2026 Feb
  •   EP4573187A1. 2025 Jun





Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.